Evommune Inc. (EVMN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Evommune Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$6.31
+22.29% today
Market cap
$187M
Overall quality
37/100
Kronos AI 30-day
+172.6%
8 of 8 simulated paths end higher
Evommune Inc. (EVMN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $187M. It trades at $6.31, up 22.29% today. Its overall quality score is 37 out of 100, ranked against the whole US market. 13 analysts' average target of $22.40 implies +255.0% from today's price. Kronos AI's 30-day forecast is +172.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.40 |
| Low – high | $8.00 – $30.00 |
| Analysts | 13 |
| Upside to average | +255.0% |
Kronos AI 30-day forecast
| Expected close | $14.07 (+172.6%) |
| Likely range | +134.3% … +228.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 9 |
| Solvency | 60 |
| Growth | 42 |
| Overall | 37 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.